Background Inhaled short‐acting anticholinergics (SAAC) and short‐acting beta₂‐agonists
(SABA) are effective therapies for adult patients with acute asthma who present to the …

Background Patients with acute asthma treated in the emergency department are frequently
treated with intermittent inhaled beta‐agonists delivered by nebulisation. The use of …

Background Inhaled beta‐agonist therapy is central to the management of acute asthma.
The use of intravenous beta‐agonist agents may also be beneficial in this setting. Objectives …

Background Inhaled beta‐agonist therapy is central to the management of acute asthma.
This review evaluates the benefit of an additional use of intravenous beta2‐agonist agents …

Background Inhaled anticholinergics given in addition to β 2‐agonists are effective in
reducing hospital admissions in children presenting to the emergency department with a …

Background There are several treatment options for managing acute asthma exacerbations
(sustained worsening of symptoms that do not subside with regular treatment and require a …

Background Inhaled beta2‐agonist therapy is central to the management of acute asthma.
For rapid bronchodilation in severe cases, penetration of inhaled drug to the affected small …

Background Asthma is a chronic condition in which sufferers may have occasional or
frequent exacerbations resulting in visits to the emergency department (ED). Aminophylline …

Patients presenting to the emergency department (ED) or clinic with acute exacerbation of
asthma (AEA) can be very challenging varying in both severity and response to therapy …

Background: Current guidelines recommend the use of a combination of inhaled β2 agonists
and anticholinergics, particularly for patients with acute severe or life threatening asthma in …